How serious is chronic ITP and how can my sister manage it?

Question

Hello doctor,

My 34-year-old sister was recently diagnosed with chronic immune thrombocytopenia (ITP) after experiencing several episodes of unexplained bruising and heavy menstrual bleeding. Her platelet count is very low, and the doctors have explained that this is due to her immune system attacking her platelets. I am very concerned. Is this condition dangerous? Could it potentially lead to internal bleeding or even a brain hemorrhage?

What treatment options are available for chronic ITP? Is it something that can be cured, or is it a condition that can only be managed or controlled over time? Additionally, are there any specific lifestyle changes or precautions she should take to help reduce her risk of bleeding and stay safe in daily life?

Kindly suggest.

Answer 1

Hello,

Welcome to iCliniq.com.

We hope you are doing well. A diagnosis of chronic immune thrombocytopenia (ITP) can understandably be concerning. Still, the good news is that with proper medical management, many individuals with ITP go on to live whole, healthy, and active lives.

While low platelet counts do increase the risk of bleeding, it is important to understand that severe complications, such as a brain hemorrhage, are very rare, occurring in less than one percent of cases. The most common issues are easy bruising, frequent nosebleeds, heavy menstrual bleeding, and in very severe cases (especially when platelet counts fall below 10,000 to 20,000 per microliter), the risk of internal bleeding becomes more significant.

Available treatment options:

Treatment is usually personalized based on symptoms and platelet count. Here is an overview of the most commonly used therapies:

First-line therapies (typically used initially):

Corticosteroids (such as Prednisone): These medications help suppress the immune system’s attack on platelets and are often the first step in treatment.
Intravenous immunoglobulin (IVIG): This is used to rapidly increase platelet levels, especially in urgent situations like active bleeding or before surgery.

Second-line therapies (if initial treatments are ineffective or not suitable for long-term use):

Thrombopoietin receptor agonists (TPO-RAs): Eltrombopag (Promacta) and Romiplostim (Nplate) stimulate the bone marrow to produce more platelets.
Rituximab (Rituxan): A targeted therapy that reduces antibody-producing B cells involved in platelet destruction.
Splenectomy (surgical removal of the spleen): Considered in chronic or treatment-resistant cases, as the spleen is often responsible for destroying platelets in ITP.

Lifestyle and safety recommendations:

To minimize bleeding risk and promote safety, the following precautions are recommended:

Avoid blood-thinning medications, including non-steroidal anti-inflammatory drugs (NSAIDs) such as Ibuprofen and Aspirin, and minimize alcohol consumption.
Choose low-impact or gentle physical activities. Avoid contact sports or any high-risk activities that might result in injury or trauma.
Manage heavy menstrual bleeding: Medications such as Tranexamic acid or hormonal therapies (for example, birth control pills) may be helpful. This should be discussed with her healthcare provider.
Dental hygiene: Use a soft-bristled toothbrush to prevent gum bleeding, and always inform dentists of her ITP diagnosis before any dental procedures.
Monitor for signs of bleeding: Watch for new bruises, bleeding gums, nosebleeds, or blood in urine or stools. Regular monitoring of platelet levels is essential.

Stay in regular contact with her hematologist, who will adjust her treatment plan as needed based on her platelet count, response to medications, and overall health.

I hope this information has been helpful.

Regards.